Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2558014

IR number 1860364
Words ARGENX
Image
Image description
Status protected: Registered/protected
Priority date 16 Sep 2024 (Convention)
Classes 5, 35, 42, 44
Kind Word
Dates
Renewal due 10 Mar 2035
Registration advertised / published 17 Apr 2026
Entered on Register 17 Apr 2026
Acceptance advertised / published 10 Feb 2026
Acceptance 10 Feb 2026
IR notification 19 Jun 2025
Filing 10 Mar 2025
Registered from 10 Mar 2025

Owner Address for service
Argenx B.V.
Spruson & Ferguson

IR Contact

Boult Wade Tennant LLP


Goods & Services
Class 5: Pharmaceuticals and medical preparations for therapeutic purposes in the field of immunology and autoimmune diseases; pharmaceutical preparations for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system; compositions of antibodies or fragments of antibodies or derivatives of antibodies with therapeutic properties; antibodies or fragments of antibodies or derivatives of antibodies for the prevention or treatment of autoimmune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, transplantation-related diseases and disorders, cancer and diseases of the immune system.
Class 35: Wholesale and retail services for therapeutic pharmaceutical preparations in the field of immunology and auto-immune diseases and antibodies or fragments or derivatives of antibodies with therapeutic properties; administrative services in relation to patient information in the field of immunology, diseases of the immune system and antibody therapeutics; business administration of patient reimbursement programs.
Class 42: Research and development in the field of immunology, antibody engineering and autoimmune diseases for therapeutic purposes; therapeutic drug research and development in the field of immunology, antibody technology and autoimmune diseases; scientific and technological services and research relating to immunity, autoimmune diseases and antibody engineering for therapeutic purposes; providing medical and scientific research information in the field of therapeutic pharmaceuticals, clinical trials, research and development.
Class 44: Providing information to patients in the field of auto-immune, antibody-mediated, neuromuscular, hematological, inflammatory, respiratory, kidney, skin, and transplantation-related diseases and disorders, cancer and diseases of the immune system and the treatment thereof; consultancy and information services relating to therapeutic biopharmaceutical products; provision of information on therapeutic pharmaceutical, medical, and healthcare products to customers or patients through an online computer network.

Endorsements

The applicant has advised that the words in the Mark have no meaning in English


Convention details
Date 16 Sep 2024
Number 1510907
Country BENELUX

Indexing constituents
Word Image